Literature DB >> 30405811

miR-221 regulates proliferation and apoptosis of ovarian cancer cells by targeting BMF.

Xinping Xie1, Yuxiu Huang1, Lihong Chen1, Jinhua Wang1.   

Abstract

To observe the expression of microRNA-221 (miR-221) in ovarian cancer tissues and its effect and associated mechanism on proliferation and apoptosis in the ovarian cancer SKOV3 cell line. The expression of miR-221 and B-cell lymphoma 2 modifying factor (BMF) mRNA in ovarian cancer and para-carcinoma tissues was detected by reverse transcription-quantitative polymerase chain reaction, the expression of BMF was detected by western blot. MicroRNA.org online predicted that BMF was the possible target gene of miR-221, and the regulatory association was validated by a dual-luciferase reporter gene assay. SKOV3 cells were divided into 8 transfection groups: Anti-miR-negative control (NC); anti-miR-221; phosphorylated internal ribosome entry site 2 (pIRES2)-blank, pIRES2-BMF, small interfering (si)-NC, si-BMF, anti-miR-221+si-BMF and anti-miR-221+pIRES2-BMF groups. Cell proliferation was detected by EdU staining flow cytometry. The effect of transfection on cell apoptosis was detected by Annexin V/PI double staining, and the activity of caspase-3 was detected by spectrophotometry. The effect of anti-miR-221 or pIRES2-BMF transfection on SKOV3 cell proliferation was detected by MTT assay and flow cytometry, and the effect on apoptosis was detected by the Annexin V/PI double staining. Compared with para-cancer tissues, the miR-221 expression was significantly upregulated (P<0.001), the BMF mRNA expression was significantly downregulated (P<0.001), and the expression of BMF proteins was significantly downregulated in the ovarian cancer tissues. Dual-luciferase reporter gene assay confirmed a targeted regulatory association between miR-221 and BMF. The anti-miR-221 or pIRES2-BMF transfection significantly upregulated BMF expression in SKOV3 cells, significantly decreased cell proliferation and significantly increased cell apoptosis. The overexpression of BMF may enhance the proapoptotic and proliferation-inhibition effect of anti-miR-221 on SKOV3 cells. The transfection of si-BMF significantly promoted cell proliferation, reduced cell apoptosis and attenuated the proapoptotic and proliferation-inhibition effect of anti-miR-221 on cells. The expression of miR-221 was significantly upregulated and the expression of BMF was significantly down-regulated in ovarian cancer tissues. The overexpression of miR-221 antagonized the apoptosis of ovarian cancer SKOV3 cell and promoted the cell proliferation by targeted inhibition of the expression of BMF, which may serve a role in the pathogenesis of ovarian cancer.

Entities:  

Keywords:  B-cell lymphoma 2 modifying factor; apoptosis; ovarian cancer; proliferation

Year:  2018        PMID: 30405811      PMCID: PMC6202478          DOI: 10.3892/ol.2018.9446

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  27 in total

1.  Hormone Use After Nonserous Epithelial Ovarian Cancer: Overall and Disease-Free Survival.

Authors:  Laura Power; Georgia Lefas; Pascal Lambert; Diane Kim; Debra Evaniuk; Robert Lotocki; Erin Dean; Mark W Nachtigal; Alon D Altman
Journal:  Obstet Gynecol       Date:  2016-05       Impact factor: 7.661

2.  Cancer statistics for Hispanics/Latinos, 2015.

Authors:  Rebecca L Siegel; Stacey A Fedewa; Kimberly D Miller; Ann Goding-Sauer; Paulo S Pinheiro; Dinorah Martinez-Tyson; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-09-16       Impact factor: 508.702

3.  Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad.

Authors:  Anna Frenzel; Verena Labi; Waldemar Chmelewskij; Christian Ploner; Stephan Geley; Heidelinde Fiegl; Alexandar Tzankov; Andreas Villunger
Journal:  Blood       Date:  2009-12-03       Impact factor: 22.113

4.  Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells.

Authors:  O Kutuk; A Letai
Journal:  Cell Death Differ       Date:  2010-04-30       Impact factor: 15.828

5.  Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties.

Authors:  Xing-Xing He; An-Yuan Guo; Chuan-Rui Xu; Ying Chang; Guang-Ya Xiang; Jing Gong; Zi-Li Dan; De-An Tian; Jia-Zhi Liao; Ju-Sheng Lin
Journal:  Oncol Rep       Date:  2014-07-03       Impact factor: 3.906

6.  The prognostic value of CXCR4 in ovarian cancer: a meta-analysis.

Authors:  Cheng-Fei Liu; Shu-Yan Liu; Xiao-Yun Min; Yuan-Yuan Ji; Na Wang; Dan Liu; Ning Ma; Zong-Fang Li; Ke Li
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

7.  MicroRNA-216a promotes the metastasis and epithelial-mesenchymal transition of ovarian cancer by suppressing the PTEN/AKT pathway.

Authors:  Haizhi Liu; Ying Pan; Xiaoxue Han; Jia Liu; Ruiman Li
Journal:  Onco Targets Ther       Date:  2017-05-23       Impact factor: 4.147

8.  Retraction: miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells.

Authors: 
Journal:  PLoS One       Date:  2017-04-10       Impact factor: 3.240

9.  Overexpression of miRNA-221 promotes cell proliferation by targeting the apoptotic protease activating factor-1 and indicates a poor prognosis in ovarian cancer.

Authors:  Jie Li; Qiang Li; He Huang; Yinguang Li; Li Li; Wenhui Hou; Zeshan You
Journal:  Int J Oncol       Date:  2017-03-07       Impact factor: 5.650

10.  Down-regulation of mir-221 and mir-222 restrain prostate cancer cell proliferation and migration that is partly mediated by activation of SIRT1.

Authors:  Xiao Yang; Yingmei Yang; Rong Gan; Lingxu Zhao; Wei Li; Huaibin Zhou; Xiaojuan Wang; Jianxin Lu; Qing H Meng
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

View more
  12 in total

1.  Delivery of Peptide Nucleic Acids Using an Argininocalix[4]arene as Vector.

Authors:  Alessia Finotti; Jessica Gasparello; Alessandro Casnati; Roberto Corradini; Roberto Gambari; Francesco Sansone
Journal:  Methods Mol Biol       Date:  2021

2.  Bioinformatic Analysis Divulged Novel Prognostic Circulating MicroRNAs and Their Potential Target Genes in Breast Cancer.

Authors:  Babak Pourgholamali; Behnoush Sohrabi; Mandana Salbi; Sanaz Akbari; Iman Rastan; Masoud Sayaf; Abduladheem Turki Jalil; Mustafa M Kadhim; Roghayeh Sheervalilou; Nazanin Mehrzad
Journal:  Appl Biochem Biotechnol       Date:  2022-09-08       Impact factor: 3.094

Review 3.  MicroRNA-221: A Fine Tuner and Potential Biomarker of Chronic Liver Injury.

Authors:  Jovana Markovic; Amar Deep Sharma; Asha Balakrishnan
Journal:  Cells       Date:  2020-07-23       Impact factor: 6.600

4.  LncRNA CASC15 Functions As An Unfavorable Predictor Of Ovarian Cancer Prognosis And Inhibits Tumor Progression Through Regulation Of miR-221/ARID1A Axis.

Authors:  Yin Shi; Shanshan Gao; Ying Zheng; Mukun Yao; Fan Ruan
Journal:  Onco Targets Ther       Date:  2019-10-23       Impact factor: 4.147

5.  A prognostic model for hepatocellular carcinoma based on apoptosis-related genes.

Authors:  Renjie Liu; Guifu Wang; Chi Zhang; Dousheng Bai
Journal:  World J Surg Oncol       Date:  2021-03-12       Impact factor: 2.754

Review 6.  miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review.

Authors:  Maria Teresa Di Martino; Mariamena Arbitrio; Daniele Caracciolo; Alessia Cordua; Onofrio Cuomo; Katia Grillone; Caterina Riillo; Giulio Caridà; Francesca Scionti; Caterina Labanca; Caterina Romeo; Maria Anna Siciliano; Maria D'Apolito; Cristina Napoli; Martina Montesano; Valentina Farenza; Valentina Uppolo; Michele Tafuni; Federica Falcone; Giuseppe D'Aquino; Natale Daniele Calandruccio; Francesco Luciano; Licia Pensabene; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  Mol Ther Nucleic Acids       Date:  2022-02-11       Impact factor: 8.886

7.  Long noncoding RNA ILF3-AS1 aggravates papillary thyroid carcinoma progression via regulating the miR-4306/PLAGL2 axis.

Authors:  Zhaohui Zeng; Qiangfeng Teng; Jinhong Xiao
Journal:  Cancer Cell Int       Date:  2021-06-27       Impact factor: 5.722

8.  PDZRN4-mediated colon cancer cell proliferation and dissemination is regulated by miR-221-3p.

Authors:  Xiaojian Liu; Chungen Xing
Journal:  Transl Cancer Res       Date:  2019-08       Impact factor: 1.241

9.  Circular RNA circYPEL2: A Novel Biomarker in Cervical Cancer.

Authors:  Xinyang Zhang; Siqi Yang; Wenbo Chen; Xin Dong; Rongyu Zhang; Haidong Ye; Xiangfei Mei; Huan Liu; Yu Fang; Chunjiang He
Journal:  Genes (Basel)       Date:  2021-12-23       Impact factor: 4.096

10.  Synergistic effects of the combined treatment of U251 and T98G glioma cells with an anti‑tubulin tetrahydrothieno[2,3‑c]pyridine derivative and a peptide nucleic acid targeting miR‑221‑3p.

Authors:  Matteo Zurlo; Romeo Romagnoli; Paola Oliva; Jessica Gasparello; Alessia Finotti; Roberto Gambari
Journal:  Int J Oncol       Date:  2021-07-19       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.